AXGN - Company ID 0000805928
Axogen, Inc. trades as AXGN and has a market capitalization of $2.33 B, making it the #2024 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $225.21M, up 20.2% from the prior year and net income of -$15.70M. This page tracks Axogen, Inc. through 1,334 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Axogen, Inc.'s revenue grew from $41.11M to $225.21M, a compound annual growth rate of 20.8%. Net profit margin expanded from -35.1% to -7.0% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-12 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
| New insider ownership | 3 | 2026-05-08 |
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
Axogen, Inc. Reports First Quarter 2026 Financial Results :: Axogen, Inc. (AXGN)
Investors interested in participating in the conference call by phone may dial toll-free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. A live webcast, an archived replay, and presentation slides from the event are available on the Investors page of the company's website at www.axogeninc.com .
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results :: Axogen, Inc. (AXGN)
Investors interested in participating in the conference call by phone may dial toll-free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. A live webcast, an archived replay, and presentation slides from the event are available on the Investors page of the company's website at www.axogeninc.com .
The largest companies sharing Axogen, Inc.'s SEC industry classification (electromedical & electrotherapeutic apparatus).
Axogen, Inc. (AXGN) has a market capitalization of $2.33 B as of 2026-07-09, ranking #2024 among US-listed companies.
Axogen, Inc. reported revenue of $225.21M for fiscal year 2025, an increase of 20.2% year over year.
In its latest fiscal year Axogen, Inc. reported a net loss of $15.70M.